| Platinum Capital Limited (PMC) ORDINARY FULLY PAID |
Financials |
- |
PMC Director Resignation and Appointment
|
18 Jun 2025 8:59AM |
$1.310 |
$1.765 |
risen by
34.73%
|
|
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$326 |
First Drill Program at Iguana Confirms Mineralisation
|
18 Jun 2025 8:58AM |
$0.029 |
$2.910 |
risen by
9,934.48%
|
|
BCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Beacon Minerals Limited completed its first drill program at the Iguana Prospect.
- Drilling results confirm the presence of significant gold mineralisation.
- The program supports Beacon’s exploration model for the area.
- Future drilling and exploration activities are planned to further test and define the mineralised zones.
- The Iguana Prospect is a key part of Beacon’s growth and exploration portfolio.
- The announcement underlines the positive implications for Beacon's future resource development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kelsian Group Limited (KLS) ORDINARY FULLY PAID |
Industrials |
$1,100 |
New Contract Workforce Transportation CP2 LNG Project
|
18 Jun 2025 8:58AM |
$3.160 |
$4.050 |
risen by
28.16%
|
|
KLS - Price-sensitive ASX Announcement
Full Release
Key Points
- Kelsian Group Limited, through Kinetic, secured a five-year contract for workforce transportation for the CP2 LNG project.
- The contract strengthens Kelsian’s position in the resources sector and supports its earnings and growth strategy.
- Kelsian’s expertise in providing large-scale transportation solutions was a key factor in winning the contract.
- The CP2 LNG project is a major liquefied natural gas infrastructure initiative in Australia.
- The contract will enhance Kelsian’s service footprint and reputation in the energy and resources industry.
- This award aligns with Kelsian’s strategic objectives to expand its presence in key growth markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 88 Energy Limited (88E) ORDINARY FULLY PAID |
Energy |
$31 |
Letter to SHSF Shareholders and Share Retention Form
|
18 Jun 2025 8:58AM |
$0.024 |
$0.024 |
fallen by
2.08%
|
|
| Platinum Asset Management Limited (PTM) ORDINARY FULLY PAID |
Financials |
$1,556 |
Update on potential merger discussions with L1
|
18 Jun 2025 8:57AM |
$0.500 |
$0.695 |
risen by
39%
|
|
PTM - Price-sensitive ASX Announcement
Full Release
Key Points
- PTM has received a non-binding indicative merger proposal from L1 Capital.
- Discussions between Platinum Asset Management and L1 Capital are in preliminary stages.
- No binding agreement has been reached regarding the merger.
- There is no certainty that a transaction will proceed.
- The Board of PTM is evaluating the proposal in the best interests of shareholders.
- PTM has appointed financial and legal advisers to assist with the evaluation.
- Shareholders are advised to take no action at this time.
- PTM will provide updates to the market as appropriate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,802 |
PTM: Update on potential merger discussions with L1
|
18 Jun 2025 8:57AM |
$2.880 |
$4.420 |
risen by
53.47%
|
|
LSF - Price-sensitive ASX Announcement
Full Release
Key Points
- PTM has entered preliminary discussions with L1 Long Short Fund Limited regarding a possible merger.
- No formal agreement or proposal has been reached at this stage.
- Discussions remain ongoing and are in the early stages.
- There is no certainty that any merger or transaction will result from these discussions.
- PTM and LSF shareholders are advised to take no action currently.
- Further updates will be provided to the market as appropriate.
- The announcement is made to comply with continuous disclosure obligations and ensure market transparency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$414 |
Update - Notification of buy-back - RG8
|
18 Jun 2025 8:54AM |
$1.920 |
$2.870 |
risen by
49.48%
|
|
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$171 |
Update - Notification of buy-back - CEH
|
18 Jun 2025 8:53AM |
$0.380 |
$0.440 |
risen by
15.79%
|
|
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - VG1
|
18 Jun 2025 8:53AM |
$1.760 |
$1.950 |
risen by
10.80%
|
|
| iTech Minerals Ltd (ITM) ORDINARY FULLY PAID |
Materials |
$10 |
Gold and Antimony Prospectivity at Reynolds Range
|
18 Jun 2025 8:52AM |
$0.027 |
$0.041 |
risen by
51.85%
|
|
ITM - Price-sensitive ASX Announcement
Full Release
Key Points
- The Reynolds Range Project is located in the Northern Territory and is wholly owned by iTech Minerals Ltd.
- The project area is prospective for both gold and antimony, supported by historic and recent exploration results.
- Significant intersections of gold and antimony mineralization have been reported from past drilling programs.
- Exploration activities have included geological mapping, geochemical sampling, and drilling, focusing on targets with historical production or anomalous results.
- The geological setting includes structurally controlled quartz veins and breccias that host mineralization.
- Notable prospects within the project include the Ooradidgee, Sabre, and Reward areas, each showing potential for further resource delineation.
- The report details the association between gold and stibnite (antimony sulfide) minerals at several prospects.
- Recent interpretations suggest that the area remains underexplored and has potential for substantial undiscovered resources.
- iTech Minerals has outlined future work programs, including additional drilling and regional exploration to follow up on encouraging results.
- The project is considered strategically important within iTech Minerals Ltd's portfolio, with potential to deliver value through discoveries of gold and antimony resources.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bastion Minerals Limited (BMO) ORDINARY FULLY PAID |
Materials |
- |
Letter to Optionholders
|
18 Jun 2025 8:52AM |
$0.002 |
$0.051 |
risen by
2,450%
|
|
BMO - Price-sensitive ASX Announcement
Full Release
Key Points
- Bastion Minerals Limited announced a pro-rata non-renounceable entitlement offer.
- The offer is only open to eligible shareholders as of the record date.
- Option holders can only participate if they exercise their options before the record date.
- To participate, option holders must pay the exercise price and follow the specified instructions.
- The offer closes at 5:00pm (AEST) on the closing date indicated in the letter.
- Option holders who do not exercise their options by the specified date will not be eligible for the entitlement offer.
- The company advises option holders to seek independent professional advice before making any decisions regarding option exercise or participation.
- Details on how to exercise options and relevant deadlines are provided in the letter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bastion Minerals Limited (BMO) ORDINARY FULLY PAID |
Materials |
- |
Letter to Ineligible Shareholders
|
18 Jun 2025 8:52AM |
$0.002 |
$0.051 |
risen by
2,450%
|
|
BMO - Price-sensitive ASX Announcement
Full Release
Key Points
- Bastion Minerals Limited is conducting a pro-rata non-renounceable entitlement offer.
- The offer is for ordinary shares at an issue price of $0.012 per share.
- Ineligible shareholders are those with registered addresses outside Australia or New Zealand.
- Ineligible shareholders will not receive entitlements or be able to participate in the offer.
- Legal and regulatory requirements prevent the company from extending the offer to ineligible shareholders.
- Any entitlements that would have been offered to ineligible shareholders will be dealt with in accordance with the terms of the offer.
- A copy of the offer document can be accessed on the ASX website or by contacting the company.
- The letter provides Bastion Minerals' contact details for shareholder questions or further information.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ironbark Balanced Income Limited (IBC) ORDINARY FULLY PAID |
Financials |
$44 |
Update - Notification of buy-back - IBC
|
18 Jun 2025 8:51AM |
$0.440 |
$0.435 |
fallen by
1.14%
|
|
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$287 |
Update - Notification of buy-back - SVR
|
18 Jun 2025 8:51AM |
$1.640 |
$1.520 |
fallen by
7.32%
|
|
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$171 |
Response to media regarding Dreamworld land DA
|
18 Jun 2025 8:51AM |
$0.380 |
$0.440 |
risen by
15.79%
|
|
| 360 Capital Group (TGP) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - TGP
|
18 Jun 2025 8:51AM |
$0.650 |
$0.300 |
fallen by
53.85%
|
|
| GTN Limited (GTN) ORDINARY FULLY PAID |
Communication Services |
$43 |
Update - Notification of buy-back - GTN
|
18 Jun 2025 8:51AM |
$0.610 |
$0.225 |
fallen by
63.11%
|
|
| Bastion Minerals Limited (BMO) ORDINARY FULLY PAID |
Materials |
- |
Non Renounceable Rights Issue Prospectus
|
18 Jun 2025 8:49AM |
$0.002 |
$0.051 |
risen by
2,450%
|
|
BMO - Price-sensitive ASX Announcement
Full Release
Key Points
- Bastion Minerals Limited is conducting a non-renounceable rights issue to raise up to approximately $2.5 million.
- The offer allows eligible shareholders to subscribe for one new share for every two shares held at $0.015 per share.
- The funds raised will be used for exploration activities, working capital, and offer-related costs.
- Key details include eligibility, acceptance instructions, timetable, and risk factors.
- The document outlines the possible impact of the offer on capital structure and control of the company.
- Disclosures are made regarding the board, management, financial position, and interests of directors.
- Potential effects on existing shareholders, including dilution, are detailed.
- The offer is not underwritten and is only available to shareholders with registered addresses in Australia and New Zealand.
- Risks associated with investing in the company and the offer are discussed in detail.
- The prospectus contains information required by the Corporations Act for such capital raisings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$22 |
Argenica to Progress Clinical Development in TBI
|
18 Jun 2025 8:49AM |
$0.705 |
$0.170 |
fallen by
75.89%
|
|
AGN - Price-sensitive ASX Announcement
Full Release
Key Points
- Argenica Therapeutics Limited (AGN) to progress clinical development of ARG-007 for traumatic brain injury (TBI).
- Preclinical studies have shown ARG-007 reduces brain damage following TBI.
- Company is preparing for the necessary clinical trials, leveraging strong preclinical efficacy and safety data.
- Argenica possesses robust intellectual property protection for ARG-007 and its potential indications.
- Strategic focus includes regulatory planning and consideration of commercial opportunities.
- ARG-007 is positioned as a novel neuroprotective therapeutic for acute brain injuries.
- The company’s decision is supported by unmet medical needs and limited current treatment options for TBI.
- Argenica is engaging with regulatory agencies to define the pathway for clinical approval.
- The announcement reinforces the company’s commitment to advancing neurotherapeutics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dart Mining NL (DTM) ORDINARY FULLY PAID |
Materials |
$7 |
Application for quotation of securities - DTM
|
18 Jun 2025 8:49AM |
$0.003 |
$0.031 |
risen by
933.33%
|
|
| Qantas Airways Limited (QAN) ORDINARY FULLY PAID |
Industrials |
$13,059 |
Section 259C Exemption Notice
|
18 Jun 2025 8:49AM |
$10.300 |
$8.630 |
fallen by
16.21%
|
|
| Cleo Diagnostics Ltd (COV) ORDINARY FULLY PAID |
Health Care |
$93 |
Investor Webinar
|
18 Jun 2025 8:48AM |
$0.350 |
$0.680 |
risen by
94.29%
|
|
| Lakes Blue Energy NL (LKO) ORDINARY FULLY PAID |
Energy |
$41 |
$6.5 million Placement to Facilitate Drilling at Wombat 5
|
18 Jun 2025 8:48AM |
$0.001 |
$0.560 |
risen by
55,900%
|
|
| INOVIQ Ltd (IIQ) ORDINARY FULLY PAID |
Health Care |
$46 |
New treatment kills 88% of Breast and Lung Cancer cells
|
18 Jun 2025 8:47AM |
$0.388 |
$0.325 |
fallen by
16.13%
|
|
IIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- INOVIQ Ltd reported a new cancer treatment that kills 88% of breast and lung cancer cells.
- The treatment uses proprietary technology developed by INOVIQ.
- Laboratory results indicate significant effectiveness against targeted cancer cell lines.
- The announcement underscores the potential impact on patient outcomes for breast and lung cancer.
- INOVIQ plans further development and clinical trials to validate the treatment's efficacy and safety.
- This innovation highlights INOVIQ's leadership in cancer diagnostics and therapy development.
- The company remains focused on advancing science to improve cancer treatment and patient care.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bastion Minerals Limited (BMO) ORDINARY FULLY PAID |
Materials |
- |
Non-Renounceable Entitlement Offer
|
18 Jun 2025 8:46AM |
$0.002 |
$0.051 |
risen by
2,450%
|
|
BMO - Price-sensitive ASX Announcement
Full Release
Key Points
- Bastion Minerals Limited is conducting a non-renounceable entitlement offer to raise approximately $1.1 million.
- Eligible shareholders can subscribe for one new share for every two existing shares at $0.04 per share.
- Subscribers will also receive one free attaching option for every two new shares subscribed, exercisable at $0.06 each on or before 30 June 2026.
- The offer opens on 17 June 2024 and closes on 1 July 2024.
- Funds raised will be used for exploration, working capital, and costs associated with the offer.
- Directors may participate in the offer.
- Shortfall shares may be placed at the Board’s discretion.
- The offer is only open to eligible shareholders with registered addresses in Australia and New Zealand as of 14 June 2024.
- BMO is the ASX code for Bastion Minerals Limited.
- Risks related to the company and the entitlement offer are outlined, including exploration risks, funding risks, and general market risks.
- Detailed instructions are provided for shareholders on how to accept or transfer entitlements, and the treatment of ineligible shareholders is specified.
- Legal and procedural information regarding the offer is included, such as tax considerations and disclaimers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
